| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $468.18M | $343.89M | $242.16M | $170.96M | $150.03M |
| R&D | $398.33M | $281.41M | $210.76M | $142.76M | $121.31M |
| SG&A | $69.85M | $62.48M | $31.40M | $28.20M | $28.72M |
| Operating Income | -$468.18M | -$343.89M | -$242.16M | -$170.96M | -$150.03M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | – | – |
| Net Income | -$446.21M | -$317.42M | -$235.94M | -$168.10M | -$149.29M |
| EPS (basic) | -3.4700 | -3.3700 | -3.9500 | -3.2300 | -2.9300 |
| EPS (diluted) | -3.4700 | -3.3700 | -3.9500 | -3.2300 | -2.9300 |
| Shares (diluted) | – | – | – | – | – |